Added value of end-users and patients involvement in a GRADEing world: insights from a case study

L. Pinsonneault, M. Fournier & V. Déry
Background: It is widely recommended that end-users and patient representatives be involved in guideline development groups (GDG). There is still some debate about the actual benefits of such involvement. Objective: To examine the effects of end-users’ and patient representatives’ involvement[for full text, please go to the a.m. URL]